FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 1 of 12 * PUBLIC *; 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

__________________________________________ 

PUBLIC 

UNITED STATES OF AMERICA 

FEDERAL TRADE COMMISSION 

OFFICE OF ADMINISTRATIVE LAW JUDGES 

) 

In the Matter of ) 

) 

Intuit, Inc., ) Docket No. 9408 

 a corporation, ) 

) 

Respondent. ) 

__________________________________________) 

ORDER ON MOTIONS FOR IN CAMERA TREATMENT 

By orders on Respondent Intuit, Inc.’s (“Respondent”) motions for in camera treatment, 

issued on March 1, and March 21, 2023, a number of Respondent’s documents were granted in 

camera treatment. Attachment A of this Order lists the documents for which in camera treatment 

was granted by those orders and for which Respondent continues to request in camera 

treatment,0F

1 the corresponding GX or RX numbers, and the in camera treatment expiration date 

for each document. For exhibits where Respondent has sought in camera treatment for a period 

of five years, the expiration date is April 1, 2028. For exhibits where Respondent has sought in 

camera treatment for a period of ten years, the expiration date is April 1, 2033. 

ORDERED: 

D. Michael Chappell 

Chief Administrative Law Judge 

Date: April 24, 2023 

1 Throughout the trial, Respondent identified certain exhibits that no longer required in camera treatment. 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 2 of 12 * PUBLIC *; 

 

 

ATTACHMENT A 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 014 Regulatory Strategy All Pages Five Years 

GX 015 Regulatory Strategy All Pages Five Years 

GX 016 Regulatory Strategy All Pages Five Years 

GX 017 Regulatory Strategy All Pages Five Years 

GX 018 Regulatory Strategy All Pages Five Years 

GX 020 Regulatory Strategy All Pages Five Years 

GX 021 Regulatory Strategy CC-00000278 Five Years 

GX 024 Regulatory Strategy All Pages Five Years 

GX 028 Regulatory Strategy All Pages Five Years 

GX 029 Regulatory Strategy All Pages Five Years 

GX 034 Regulatory Strategy All Pages Five Years 

GX 035 Regulatory Strategy All Pages Five Years 

GX 038 Regulatory Strategy All Pages Five Years 

GX 040 Regulatory Strategy All Pages Five Years 

GX 051 Regulatory Strategy All Pages Five Years 

GX 068 Regulatory Strategy CC-00000721; 724 Five Years 

GX 069 Regulatory Strategy CC-00000727; 728 Five Years 

GX 070 Regulatory Strategy CC-00000729; 739 Five Years 

GX 071 Regulatory Strategy CC-00000752; 754; 760–762; 

772–774; 780–782; 784 

Five Years 

GX 080 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

CC-00000838–841; 845–848; 

850; 858–862; 868–874; 876– 

878; 886–888 

Ten Years 

GX 081 Regulatory Strategy All Pages Five Years 

GX 092 Regulatory Strategy CC-00000961; 971 Five Years 

GX 103 Regulatory Strategy All Pages Five Years 

1

 Where in camera treatment has been granted for only a portion of a page, that portion has been identified with 

yellow highlighting in confidential versions of the exhibits provided to the Court. 

A-1 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 3 of 12 * PUBLIC *; 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 108 Regulatory Strategy CC-00001083; 089 Five Years 

GX 114 Regulatory Strategy All Pages Five Years 

GX 152 Sales and Marketing Strategy CC-00003883; 3884; 3900–3902; 

4013; 4022; 4054; 4055 

Five Years 

GX 153 Regulatory Strategy CC-00004247–249 Five Years 

GX 155 Regulatory Strategy; Sales and 

Marketing Strategy 

CC-00004722; 723; 727; 732– 

738; 741–744 

Five Years 

GX 157 Regulatory Strategy; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

CC-00005003–007; 101–106; 

108–112; 115–118 

Ten Years 

GX 296 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

CC-00006358; 359; 361–365; 

368; 369; 372–403; 405; 407–409 

Ten Years 

GX 297 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy; Trade 

Secrets and Product Development 

CC-00006418; 425–429; 431; 

432; 434–440 

Ten Years 

GX 392 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 393 Business Strategy/Strategic 

Initiatives; Trade Secrets and 

Product Development 

All Pages Ten Years 

GX 394 Business Strategy/Strategic 

Initiatives; Trade Secrets and 

Product Development 

All Pages Ten Years 

GX 395 Pricing and Pricing Strategy All Pages Five Years 

GX 396 Business Strategy/Strategic 

Initiatives; Financial Data; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 397 Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 398 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 399 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 400 Business Strategy/Strategic 

Initiatives 

All Pages Five Years 

GX 401 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 402 Business Strategy/Strategic 

Initiatives; Financial Data; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 403 Business Strategy/Strategic 

Initiatives; Financial Data; Trade 

Secrets and Product Development 

All Pages Ten Years 

A-2 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 4 of 12 * PUBLIC *; 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 409 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 409-A Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 410 Business Strategy/Strategic 

Initiatives; Financial Data; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 428 Business Strategy/Strategic 

Initiatives; Financial Data; 

Regulatory Strategy; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 431 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Column N Ten Years 

GX 432 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Column N Ten Years 

GX 433 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Column N Ten Years 

GX 434 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Columns E-G Ten Years 

GX 435 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Columns G-H Ten Years 

GX 436 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Columns N-O Ten Years 

GX 437 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Columns N-O Ten Years 

GX 441 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 442 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 443 Business Strategy/Strategic 

Initiatives 

All Pages Five Years 

GX 444 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 451 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 452 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

A-3 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 5 of 12 * PUBLIC *; 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 452-A Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 453 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 453-A Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 456 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 457 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 461 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 472 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 473 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 631 Trade Secrets and Product 

Development 

CC-00013293; 296; 297; 299–300 Ten Years 

GX 634 Sales and Marketing Strategy All Pages Five Years 

GX 635 Sales and Marketing Strategy All Pages Five Years 

GX 636 Business Strategy/Strategic 

Initiatives; Pricing and Pricing 

Strategy; Sales and Marketing 

Strategy; Trade Secrets and 

Product Development 

All Pages Ten Years 

GX 637 Business Strategy/Strategic 

Initiatives 

All Pages Five Years 

GX 638 Business Strategy/Strategic 

Initiatives; Financial Data 

All Pages Five Years 

GX 639 Business Strategy/Strategic 

Initiatives; Financial Data 

All Pages Five Years 

GX 641 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

GX 643 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

A-4 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 6 of 12 * PUBLIC *; 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 644 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 645 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 646 Sales and Marketing Strategy All Pages Five Years 

GX 648 Sales and Marketing Strategy All Pages Five Years 

GX 649 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 651 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

CC-00013979–994 Ten Years 

GX 653 Sales and Marketing Strategy All Pages Five Years 

GX 655 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 656 Sales and Marketing Strategy All Pages Five Years 

GX 658 Financial Data; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

GX 659 Business Strategy/Strategic 

Investments; Financial Data; 

Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 660 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 661 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 662 Sales and Marketing Strategy All Pages Five Years 

GX 664 Sales and Marketing Strategy All Pages Five Years 

GX 665 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

GX 673 Sales and Marketing Strategy All Pages Five Years 

GX 681 Sales and Marketing Strategy All Pages Five Years 

GX 682 Sales and Marketing Strategy All Pages Five Years 

GX 683 Sales and Marketing Strategy All Pages Five Years 

GX 688 Sales and Marketing Strategy All Pages Five Years 

A-5 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 7 of 12 * PUBLIC *; 

 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

GX 689 Sales and Marketing Strategy All Pages Five Years 

GX 690 Sales and Marketing Strategy All Pages Five Years 

GX 743 Sales and Marketing Strategy CC-00015149–150; 172; 174– 

181; 183–189; 191; 192 

Five Years 

GX 745 Financial Data All Pages Five Years 

GX 746 Financial Data All Pages Five Years 

GX 747 Financial Data All Pages Five Years 

GX 749 Financial Data; Sales and 

Marketing Strategy 

CC-00015313; 314, 316; 319; 

320; 331; 333; 337; 338; 349 

Five Years 

GX 765 Sales and Marketing Strategy All Pages Five Years 

GX 857 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 858 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 859 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 860 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 861 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 862 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 863 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 864 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 865 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 866 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 867 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX 868 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

GX Summary 

0012 

Sales and Marketing Strategy Column N of sixth tab Five Years 

GX Summary 

002 

Sales and Marketing Strategy Columns F–G of first tab; 

columns E–G of second tab 

Five Years 

RX 039 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy; Trade Secrets and 

Product Development 

All Pages Ten Years 

RX 045 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

2

 GX Summary 001 and 002 are revised versions of Megan Baburek’s summary exhibits. In camera treatment was 

granted for the original versions of these exhibits, RX 1388 and 1389, in the March 21 Order. 

A-6 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 8 of 12 * PUBLIC *; 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

RX 049 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

RX 050 Financial Data; Pricing and 

Pricing Strategy 

All Pages Five Years 

RX 051 Business Strategy/Strategic 

Initiatives; Financial Data; 

Pricing and Pricing Strategy 

All Pages Five Years 

RX 052 Trade Secrets and Product 

Development; Sales and 

Marketing Strategy 

All Pages Ten Years 

RX 053 Business Strategy/Strategic 

Initiatives; Financial Data; 

Pricing and Pricing Strategy; 

Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

RX 054 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy 

All Pages Five Years 

RX 055 Trade Secrets and Product 

Development 

All Pages Ten Years 

RX 057 Sales and Marketing Strategy Pages 1–21; 23–32 Five Years 

RX 057-A Sales and Marketing Strategy Pages 1–21; 23–32 Five Years 

RX 059 Financial Data; Pricing and 

Pricing Strategy 

All Pages Five Years 

RX 060 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

RX 061 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

RX 065 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

Pages 3–6; 10–13; 15; 23–27; 33– 

39; 41–43; 51–53 

Ten Years 

RX 067 Arbitration Document All Pages Five Years 

RX 068 Arbitration Document All Pages Five Years 

RX 069 Arbitration Document All Pages Five Years 

RX 106 Financial Data All Pages Five Years 

RX 121 Sensitive Personal Information All Pages Indefinite 

RX 137 Sensitive Personal Information All Pages Indefinite 

RX 146 Sensitive Personal Information All Pages Indefinite 

RX 153 Sensitive Personal Information All Pages Indefinite 

RX 157 Sensitive Personal Information All Pages Indefinite 

RX 207 Sensitive Personal Information All Pages Indefinite 

RX 223 Sensitive Personal Information All Pages Indefinite 

A-7 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 9 of 12 * PUBLIC *; 

 

 

 

 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

RX 232 Sensitive Personal Information All Pages Indefinite 

RX 239 Sensitive Personal Information All Pages Indefinite 

RX 260 Pricing and Pricing Strategy; 

Trade Secrets and Product 

Development 

Pages 3; 4; 8; 12; 14; 18–21; 23; 

24 

Ten Years 

RX 298 Business Strategy/Strategic 

Initiatives; Financial Data; 

Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 310 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

RX 312 Financial Data; Pricing and 

Pricing Strategy; Sales and 

Marketing Strategy 

All Pages Five Years 

RX 322 Business Strategy/Strategic 

Initiatives; Financial Data; 

Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 325 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

RX 334 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

RX 365 Sales and Marketing Strategy All Pages Five Years 

RX 366 Sales and Marketing Strategy All Pages Five Years 

RX 368 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

All Pages Five Years 

RX 371 Sales and Marketing Strategy All Pages Five Years 

RX 377 Business Strategy/Strategic 

Initiatives; Financial Data 

All Pages Five Years 

RX 383 Arbitration Document All Pages Five Years 

RX 384 Arbitration Document All Pages Five Years 

RX 384-A Arbitration Document All Pages Five Years 

RX 385 Arbitration Document All Pages Five Years 

RX 385-A Arbitration Document All Pages Five Years 

RX 386 Arbitration Document All Pages Five Years 

RX 392 Sales and Marketing Strategy Page 7 Five Years 

RX 401 Financial Data; Sales and 

Marketing Strategy 

Pages 3; 8; 9; 21; 24; 29–34; 57; 

58; 60–63; 65; 72–75; 77; 79–82; 

85; 86; 91–94; C-1 to C-3; D2 

Five Years 

A-8 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 10 of 12 * PUBLIC *; 

 

 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

RX 402 Financial Data; Sales and 

Marketing Strategy 

Pages 38; 42; 45; 46; B-1 Five Years 

RX 571 Financial Data All Pages Five Years 

RX 572 Financial Data All Pages Five Years 

RX 573 Financial Data All Pages Five Years 

RX 574 Financial Data All Pages Five Years 

RX 575 Financial Data All Pages Five Years 

RX 576 Financial Data All Pages Five Years 

RX 579 Sales and Marketing Strategy; 

Trade Secrets and Product 

Development 

All Pages Ten Years 

RX 582 Sales and Marketing Strategy Pages 24; 25; 49; 67 Five Years 

RX 592 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy; Trade Secrets and 

Product Development 

All Pages Ten Years 

RX 594 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy 

All Pages Five Years 

RX 596 Sales and Marketing Strategy All Pages Five Years 

RX 599 Financial Data; Pricing and 

Pricing Strategy; Sales and 

Marketing Strategy 

Pages 3; 4; 8; 12; 14; 18–21; 23; 

24 

Five Years 

RX 600 Financial Data; Pricing and 

Pricing Strategy; Sales and 

Marketing Strategy 

Pages 6–10 and 32; Statement of 

Material Facts 1; 2; 4–6; 11; 15; 

16 

Five Years 

RX 698 Financial Data; Sales and 

Marketing Strategy 

All Pages Five Years 

RX 704 Financial Data; Pricing and 

Pricing Strategy 

All Pages Five Years 

RX 706 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy; Trade Secrets and 

Product Development 

All Pages Ten Years 

RX 723 Financial Data; Pricing and 

Pricing Strategy; Sales and 

Marketing Strategy; Trade 

Secrets and Product Development 

All Pages Ten Years 

RX 765 Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 765-A Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 795 Financial Data; Pricing and 

Pricing Strategy 

All Pages Five Years 

A-9 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 11 of 12 * PUBLIC *; 

 

 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

RX 804 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

Pages 1–19; 25–163 Five Years 

RX 809 Sales and Marketing Strategy All Pages Five Years 

RX 810 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy 

All Pages Five Years 

RX 811 Business Strategy/Strategic 

Initiatives; Financial Data; Sales 

and Marketing Strategy 

All Pages Five Years 

RX 812 Pricing and Pricing Strategy All Pages Five Years 

RX 814 Business Strategy/Strategic 

Initiatives; Sales and Marketing 

Strategy 

Pages 3–17 Five Years 

RX 815 Sales and Marketing Strategy All Pages Five Years 

RX 817 Sales and Marketing Strategy All Pages Five Years 

RX 818 Sales and Marketing Strategy All Pages Five Years 

RX 819 Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 820 Pricing and Pricing Strategy; 

Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

RX 821 Pricing and Pricing Strategy; 

Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

RX 822 Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 823 Pricing and Pricing Strategy; 

Sales and Marketing Strategy 

All Pages Five Years 

RX 825 Sales and Marketing Strategy All Pages Five Years 

RX 1016 Financial Data; Sales and 

Marketing Strategy 

Pages 19 and 20 Five Years 

RX 1016-A Financial Data; Sales and 

Marketing Strategy 

Pages 19 and 20 Five Years 

RX 1017 Financial Data; Sales and 

Marketing Strategy 

Pages 54; 67; 69; 70; 73; 75; 78; 

84; 85; 91; B-2; C-1-16 

Five Years 

RX 1018 Financial Data; Sales and 

Marketing Strategy 

Pages 12; 18; 20; 22; 23; 28; 32– 

35; 37; 38; 44; 47; 53; 54; 92; 93; 

95; 97; 99; 124; 126–130; 133; 

136; 144; 145; C-3; C-4; C-14; F2 

Five Years 

A-10 
FEDERAL TRADE COMMISSION | OFFICE OF THE SECRETARY | FILED 4/24/2023 | Document No. 607558 | PAGE Page 12 of 12 * PUBLIC *; 

 

 

 

 

 

PUBLIC

Exhibit No. In Camera Treatment Partial or Complete In Camera 

Treatment1 

Duration of In 

Camera Treatment 

RX 1027 Financial Data; Sales and 

Marketing Strategy 

Pages 2; 14; 17; 19; 33; 38; 44; 

46; 47; 49–51; 54; 56–58; 61–72; 

79; 82; 83; 85; 88; 94; 97; 98; 

102; 103; 106–109; 111–115; B17; C-33; D-3; D-6; D-10; D-11 

to D-13; D-15 to D-17; D-19; D21; D-23 to D-27; D-29 to D-32; 

D-34 to D-39 

Five Years 

RX 1030 Sales and Marketing Strategy All Pages Five Years 

RX 1345 Financial Data; Sales and 

Marketing Strategy 

Pages 84; 85; 87; 90; 91; 102; 

104; 108; 109; 120 

Five Years 

RX 1362 Sales and Marketing Strategy Pages 6; 7; 29; 31–38; 40–46; 48; 

49 

Five Years 

RX 1368 Financial Data; Sales and 

Marketing Strategy 

B-17 Five Years 

RX 1372 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

RX 1373 Sales and Marketing Strategy; 

Sensitive Personal Information 

All Pages Indefinite 

RX 1374 Sales and Marketing Strategy All Pages Five Years 

RX 1375 Sales and Marketing Strategy All Pages Five Years 

RX 1376 Sales and Marketing Strategy All Pages Five Years 

RX 1385 Financial Data; Sales and 

Marketing Strategy 

All Pages Five Years 

RX 1386 Financial Data; Sales and 

Marketing Strategy 

All Pages Five Years 

RX 1388 Sales and Marketing Strategy Columns F–G of first tab; 

columns E–G of second tab 

Five Years 

RX 1389 Sales and Marketing Strategy Column N of second tab Five Years 

RX 1394 Financial Data; Sales and 

Marketing Strategy 

Page 140 Five Years 

RX 1395 Financial Data; Sales and 

Marketing Strategy 

Pages 60; 93–95; 137; 141–143; 

147; 149; 150; 166–171; 177; 

178; 180–183 

Five Years 

RX 1396 Financial Data; Sales and 

Marketing Strategy 

Pages 147–148; 150; 317–323 Five Years 

RX 1543 Sales and Marketing Strategy All Pages Five Years 

RX 1544 Sales and Marketing Strategy All Pages Five Years 

RX 1545 Sales and Marketing Strategy All Pages Five Years 

RX 1546 Sales and Marketing Strategy All Pages Five Years 

A-11